Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5IMX

Anaplastic lymphoma kinase (ALK) catalytic domain complexed with novel inhibitor 3-sulfonylpyrazol-4-amino pyrimidine

5IMX の概要
エントリーDOI10.2210/pdb5imx/pdb
分子名称ALK tyrosine kinase receptor, 5-chloro-N~2~-{5-methyl-4-(1-methylpiperidin-4-yl)-2-[(propan-2-yl)oxy]phenyl}-N~4~-{1-methyl-3-[(propan-2-yl)sulfonyl]-1H-pyrazol-4-yl}pyrimidine-2,4-diamine (3 entities in total)
機能のキーワードkinase, inhibitor, transferase-transferase inhibitor complex, transferase/transferase inhibitor
由来する生物種Homo sapiens (Human)
細胞内の位置Cell membrane ; Single-pass type I membrane protein : Q9UM73
タンパク質・核酸の鎖数1
化学式量合計37485.51
構造登録者
Wang, C.,Zhang, P.,Dong, J. (登録日: 2016-03-07, 公開日: 2016-05-04, 最終更新日: 2024-03-20)
主引用文献Zhang, P.,Dong, J.,Zhong, B.,Zhang, D.,Yuan, H.,Jin, C.,Xu, X.,Li, H.,Zhou, Y.,Liang, Z.,Ji, M.,Xu, T.,Song, G.,Zhang, L.,Chen, G.,Meng, X.,Sun, D.,Shih, J.,Zhang, R.,Hou, G.,Wang, C.,Jin, Y.,Yang, Q.
Design and synthesis of novel 3-sulfonylpyrazol-4-amino pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors.
Bioorg.Med.Chem.Lett., 26:1910-1918, 2016
Cited by
PubMed: 26979157
DOI: 10.1016/j.bmcl.2016.03.017
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.12 Å)
構造検証レポート
Validation report summary of 5imx
検証レポート(詳細版)ダウンロードをダウンロード

218853

件を2024-04-24に公開中

PDB statisticsPDBj update infoContact PDBjnumon